Condition: Nasopharyngeal Carcinoma
Intervention: Procedure: EUS-FNA for RPLN in NPC patients
Sponsor: Sun Yat-sen University
Recruiting - verified December 2016
AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol - Introduction Sepsis is a leading global cause of morbidity and mortality, and is more common at the extremes of age. Moreover, the cost of in-hospital car...